DYNAMIC DATE CHAIN FOUNDATION LTD.
UEN: 201838630D
DYNAMIC DATE CHAIN FOUNDATION LTD.(201838630D) is a Singapore business with registered business address at 60 PAYA LEBAR ROAD, 8-55, PAYA LEBAR SQUARE, Singapore 409051. They specialise in the area of DEVELOPMENT OF OTHER SOFTWARE AND PROGRAMMING ACTIVITIES N.E.C. and MANAGEMENT OF HUMAN RESOURCE FUNCTIONS.
| Company Name | DYNAMIC DATE CHAIN FOUNDATION LTD. |
| Unique Entity Number | 201838630D |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 14 November 2018 |
| Address |
60 PAYA LEBAR ROAD #8-55 PAYA LEBAR SQUARE Singapore 409051 |
| Products / Services |
DEVELOPMENT OF OTHER SOFTWARE AND PROGRAMMING ACTIVITIES N.E.C. MANAGEMENT OF HUMAN RESOURCE FUNCTIONS |
| Number of Officers | 3 |
Breaking! Business News
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform expansion in AsiaCongenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform e...
Read More
Giving Back, Changing Lives: inCruises Partners with Mercy Ships to Transform Lives in AfricaGiving Back, Changing Lives: inCruises Partners with Mercy Ships to Transform Lives in AfricaGlobeN...
Read More
Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual MeetingImmunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical ...
Read More
Global Smart Commodity Group to host Aloe Contracts on Salus PlatformGlobal Smart Commodity Group to host Aloe Contracts on Salus PlatformGlobeNewswireApril 12, 2021CHIC...
Read More
IIA Signs MOU with Vietnam’s Ministry of FinanceIIA Signs MOU with Vietnam’s Ministry of FinanceCollaboration focuses on furthering the mission of...
Read More
NMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who Failed Platinum-Containing Chemotherapy or Progressed within 12 Months of Neoadjuvant or Adjuvant Platinum-Containing ChemotherapyNMPA Approves Toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma who F...
Read More
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone fo...
Read More
Colliers releases first Global Impact ReportColliers releases first Global Impact ReportDevelopment of full impact position and comprehensive st...
Read More